89 results
Page 3 of 5
DRS
kih47zypo
26 Aug 21
Draft registration statement
12:00am
8-K
EX-2.1
4t5 w1ai5mn565p
10 Aug 21
Maravai Lifesciences Reports Second Quarter Financial Results and Updates 2021 Financial Guidance
4:18pm
8-K
EX-99.1
zy099k7c2 l32
10 Aug 21
Maravai Lifesciences Reports Second Quarter Financial Results and Updates 2021 Financial Guidance
4:18pm
10-Q
y9jq8y4t 2rj0
12 May 21
Quarterly report
4:26pm
8-K
EX-99.1
kz641af
10 May 21
Maravai Lifesciences Reports First Quarter Financial Results and Updates 2021 Financial Guidance
4:21pm
424B4
lus kctu4pl1k
9 Apr 21
Prospectus supplement with pricing info
4:02pm
8-K
EX-99.1
hfw pu01zqz75d4h
5 Apr 21
Maravai Lifesciences Announces Preliminary Unaudited First Quarter Revenues and Income from Operations Range
5:15pm
DRS
p3u55kb6h77h91b2xpms
25 Mar 21
Draft registration statement
12:00am
10-K
EX-4.2
zh1l4v10 ht13xb
22 Mar 21
Annual report
4:22pm
10-K
f9qjv3znc5k0j 5i
22 Mar 21
Annual report
4:22pm
8-K
EX-99.1
sok49sj75utf6
2 Mar 21
Maravai Lifesciences Reports Fourth Quarter and Full Year 2020 Financial Results and Initiates 2021 Financial Guidance
4:18pm
8-K
EX-4.1
yjzw alcmpolzgiio4
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
8-K
EX-10.8
tsucy9juj52cy3mox7mv
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
8-K
EX-10.10
efufbioremyvw6s82sud
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
8-K
EX-10.9
ikn5s h4ow08m
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
424B4
8fmxdmhac45 s6hzml8l
23 Nov 20
Prospectus supplement with pricing info
4:36pm